Literature DB >> 20546480

Drug rash with eosinophilia and systemic symptoms secondary to sulfasalazine.

Jeremy Rosenbaum1, George Alex, Hugh Roberts, David Orchard.   

Abstract

A severe cutaneous eruption in an unwell patient can be a major cause of physician anxiety. With numerous differential diagnoses, an early accurate diagnosis can be challenging. infectious causes are the most important to exclude in a timely manner and drug rash and eosinophilia with systemic symptoms (DRESS) is another differential diagnosis that should be considered in children. This hypersensitivity reaction is associated with multisystem involvement. Children with underlying chronic diseases may have impairment of normal metabolic pathways and are also often on multiple medications. Therefore, drugs should always be considered in the aetiopathology of any new symptoms and signs. This case report informs readers of the association of sulfasalazine and DRESS in an 11-year-old with inflammatory bowel disease and discusses its pathogenesis and treatment. Increased awareness of this disorder will hopefully lead to increased reporting and consequently illuminate the syndrome more clearly and help guide its prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20546480     DOI: 10.1111/j.1440-1754.2009.01660.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  3 in total

1.  Drug rash with eosinophilia and systemic symptoms: two emergency department cases.

Authors:  Alina Tsyrulnik; Adam Landman
Journal:  West J Emerg Med       Date:  2011-11

2.  Drug reaction with eosinophilia and systemic symptoms (DRESS) in children.

Authors:  Francesca Mori; Carlo Caffarelli; Silvia Caimmi; Paolo Bottau; Lucia Liotti; Fabrizio Franceschini; Fabio Cardinale; Roberto Bernardini; Giuseppe Crisafulli; Francesca Saretta; Elio Novembre
Journal:  Acta Biomed       Date:  2019-01-29

3.  Dermatological Manifestations in Pediatric Inflammatory Bowel Disease.

Authors:  Smaranda Diaconescu; Silvia Strat; Gheorghe G Balan; Carmen Anton; Gabriela Stefanescu; Ileana Ioniuc; Ana Maria Alexandra Stanescu
Journal:  Medicina (Kaunas)       Date:  2020-08-23       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.